| Thanks very much for allowing me to appear before you
today. It is a real honor to have this opportunity to work with the
President's Committee of Advisers on Science & Technology (PCAST).
The Commerce Department, and my Technology Administration, look forward
to working with PCAST on ways we can together support American innovation,
entrepreneurship and global technology leadership.
I am here today wearing three hats:
- an Administration official who works with technology industry
leaders on a daily basis;
- leader of the office that chairs the Interagency Working Group
on Technology Transfer; and
- senior official from the Commerce Department.
My message, in summary, is that PCAST should first do no harm.
The Bayh-Dole legislative framework is not broken - in fact, it
is working extremely well in the opinion of many - and thus should
not be significantly altered. Certainly substantial changes are
not warranted without a thorough review and investigation, tapping
the knowledge and expertise of the federal agencies and the private
sector. Such an investigation may be more fruitful if focused on
the entire technology transfer system and not one element in isolation.
In addition, I am here to offer the resources of my office to PCAST.
We spend a lot of time working with experts and practitioners, trying
to understand the barriers to and improve the effectiveness of tech
transfer, efforts that should help this subcommittee. I'll identify
some of our efforts and conclude with some specific recommendations
for PCAST going forward.
1. What We're Hearing from Industry
The Technology Administration meets with industry leaders daily.
Industry representatives routinely bring their issues and concerns
to us. Just as often, we proactively ask them what policy changes
might better support their efforts to innovate and create jobs.
In fact we advertise ourselves as the tech industry's "portal"
to the Bush Administration. During hundreds of discussions, industry
has raised issues that range across the spectrum - including spectrum,
tax policy, standards, R&D funding, IPR protection, trade and
export regulations, e-commerce rules, workforce needs, and broadband,
just to name a few. To date, no industry representative has lobbied
us on the need to rewrite Bayh-Dole. To the contrary, many industries
(such as biotech) have clearly indicated that this legislation is
working extremely well as is.
Of course everyone in industry we have asked would prefer greater
control over intellectual property financed by the federal government.
Who wouldn't? And certainly industry representatives have expressed
frustration about burdens associated with dealing with the federal
government, from contracting to tech transfer to paying taxes. But
the Bayh-Dole framework consistently ranks low on the list of problems,
well below accounting standards, federal acquisition regulations,
alleged federal R&D portfolio imbalances, annual changes in
Congressional funding priorities, liability exposure, and difficulties
in working with risk averse government lawyers. In regard to federal
tech transfer rules and procedures, we do hear about the inconsistent
interpretations and practices that exist across the federal departments
and agencies, as well as the failure of the agencies to empower
tech transfer officials to make deals - before running them through
lawyers, committees, and headquarters. But not about the essential
principles embodied in Bayh-Dole.
While PCAST should certainly seek direct industry feedback - especially
those who are actually transferring technology and ideally not just
the big guys - our experience suggests Bayh-Dole is not a top tier
concern for most in industry, and that the framework it establishes
is working.
2. What We're Hearing from Federal Labs
Our office leads the Interagency Working Group on Technology Transfer
(IWGTT), comprising technology transfer practitioners and coordinators
from all federal agencies with extramural research programs. For
almost two decades, this working group has met monthly and played
a central role in guiding policy makers on the real-world practices
and implications of our tech transfer laws, helping agencies see
and consider their colleagues' best practices, and coordinating
submission of data for congressional reports.
While PCAST can and should coordinate this question with the federal
agencies that have experience working under Bayh-Dole, the feedback
we have gotten has overwhelmingly supported the existing Bayh-Dole
framework. A few agencies, notably DoD, suggest government may get
greater industry partnership for acquisitions by surrendering more
intellectual property rights to industry. NIH, by contrast, has
had extraordinary success in tech transfer under Bayh-Dole and sees
no reason to cede more control to private sector players. Overall,
IWGTT representatives share our recommendation to "first, do
no harm" to a system that works pretty well. (It is worth noting
that there is also some concern about the process at work here,
with PCAST requests for all "problems and concerns with Bayh-Dole
" suggesting a predetermined intention to recommend changes).
3. What We're Hearing from Commerce Department
The Department of Commerce believes that Bayh-Dole strikes the
appropriate balance between the public interest and needed market
incentives. The wide dissemination and use of the federal science
and technology resulting from the taxpayers' substantial investments
in government R&D is in the public interest and should be preserved.
Strong incentives to the private sector to commercialize the new
technologies and innovations that arise from these efforts are also
needed and important. Bayh-Dole strikes a very reasonable balance,
and we would be concerned that major changes might upset this careful
framework. We note that other countries, including Japan and France,
have recently adopted Bayh-Dole-like legislation, precisely because
it has been so successful in the United States. There may be ways
to improve the tech transfer process - such as clarifying or modifying
the "substantially manufactured" requirement, improving
guidelines for interpreting the "reasonable and necessary"
test for granting exclusive licenses to government-owned inventions
(at some federal labs such as NIST) and modifying or limiting appeals
rights where license applications are denied - but these should
be narrowly tailored and carefully considered.
It is also worth considering the purpose and importance of existing
processes to patent (and make public) federally-funded innovations.
Ensuring these ideas are widely used and widely disseminated allows
further innovation, building upon this public science and ensuring
returns on federal investments in science and technology. Recent
U.S. industrial patents owe greatly to the results of publicly funded
R&D - and particularly so in important industrial sectors such
as biomedicine/biotech. The National Science Foundation determined
in 1997 that 73% of the scientific papers cited on the front pages
of U.S. industry patents came from public science (The Increasing
Linkage between U.S. Technology & Public Science, CHI Research,
Inc., Mar., 1997, www.chiresearch.com/nltv1.htm). Allowing private
companies to hold the fruits of public science as trade secrets
would likely diminish the long run productivity of the nation's
innovation system underpinned by federal funding of S&T, and
we recommend against such efforts.
4. What We're Doing at the Office of Technology Policy, U.S. Department
of Commerce
Several of our activities at the Office of Technology Policy (within
the Technology Administration at the U.S. Commerce Department) may
be of interest to this working group. These include:
- EXAMINING INNOVATION IN AMERICA: We are leading the Innovation
in America roundtable series, designed to bring together leaders
in R&D and innovation from U.S. industry, universities and government
laboratories to explore the changing innovation landscape; to inform
R&D policymakers, practitioners and managers; and to identify
trends and understand their implications for national R&D and
innovation policies and programs. We included PCAST representatives
in every meeting, and at the request of Dr. Marburger, we have provided
transcripts of these sessions to this subcommittee. We are excited
to have Dr. Clough and Dr. Fox joining us in June for our discussion
of University R&D, discussions with will include the issues
of industry-government-university partnerships, tech transfer and
Bayh-Dole.
- TECH TRANSFER. By statute, our office has the federal government
lead on examining, reporting on and recommending changes to the
1980 Bayh-Dole and Stevenson-Wydler Acts and related technology
transfer policies. These laws have helped distinguish America from
other nations with large federal investments in R&D by trying
to set a rational, predictable and consistent framework for determining
IPR. Our office listens to all sides, trying to ensure the rules
continue to maximize innovation and commercialization of federally-funded
ideas. Based upon these efforts we believe Bayh-Dole cannot and
should not be isolated from the broader tech transfer framework
when considering ways to improve the process.
- IWGTT. Our office leads the Interagency Working Group on Technology
Transfer, described above.
- CONGRESSIONAL REPORTING. Under the Tech Transfer Act of 2000
and prior legislation, the Office of Technology Policy is tasked
with preparing reports to Congress detailing the state of technology
transfer. We view our role as much more than merely compiling and
forwarding this data, working with agencies to ensure the data has
meaning and appropriate interpretation. It is imperative that we
find ways to measure what we value and not merely value what we
measure, and we try to work with federal agencies to be sure Congress
is measuring the right things.
- REPORT ON FOREIGN PARTICIPATION. The Tech Transfer Act of 2000
also required NSTC to prepare a report on foreign participation
in federally-funded R&D. NSTC asked our office to put that report
together. We are compiling data to evaluate the frequency of agreements
between U.S. labs and foreign companies, as well as agency practices
in managing such relationships. We are trying to develop recommendations
about how to make information about foreign reciprocity in IP and
cooperative research more readily available to federal labs and
agencies, and developing recommendations for revisions to EO 12592.
- REVIEW OF LABS' ROLE IN COMMUNITIES. We also spend a lot of our
time looking at state and regional business climate policies, trying
to better explain the dynamics needed to sustain tech-led economic
growth. One of our projects under way right now is a review of efforts
at 10 federal labs that are partnering effectively with local communities
to advance regional economies. We hope to issue this report before
the end of the calendar year.
5. Recommendations for Going Forward
In light of two decades of success at Universities, lack of significant
or consistent industry concern, and on-the-whole federal agency
support, we would recommend against proposing any significant changes
to Bayh-Dole at the June PCAST meeting. Instead we'd suggest PCAST
(1) reiterate the value and importance of tech transfer in our innovation
system; (2) consider Bayh-Dole in context of the entire tech transfer
system and not in isolation; and (3) work with the Office of Technology
Policy at the Commerce Department to identify what is working and
what might be fixed by executive action within the larger framework.
Thanks once again for inviting me here today. I look forward to
our discussion.
|